Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 3Multiple Myeloma 3Pneumonia, Pneumococcal 1Ovarian Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Fallopian Tube Neoplasms 1

Interventions

fludarabine phosphate 15Cyclophosphamide 13Whole-Body Irradiation 12Peripheral Blood Stem Cell Transplantation 12Tacrolimus 10Etoposide 10Rituximab 8Mycophenolic Acid 8Methotrexate 6Melphalan 6Cyclosporine 6Busulfan 6Antilymphocyte Serum 6Vorinostat 4Sirolimus 4Prednisone 4Lenalidomide 4Immunohistochemistry 4Gene Expression Profiling 4Carboplatin 4Vincristine 3Microarray Analysis 3Gemcitabine 3Everolimus 3Doxorubicin 3Dexamethasone 3Brentuximab Vedotin 3Alemtuzumab 310-propargyl-10-deazaaminopterin 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunoblastic Lymphadenopathy × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡